Primary and secondary ethical issues arising from the introduction of recombinant factor VIII: "primum non nocere," but what next?
作者信息
McDonald M
机构信息
Centre for Applied Ethics, University of British Columbia, Vancouver, Canada.
出版信息
Transfus Med Rev. 1992 Oct;6(4):271-6. doi: 10.1016/s0887-7963(92)70181-3.
PMID:1421828
Abstract
摘要
相似文献
1
Primary and secondary ethical issues arising from the introduction of recombinant factor VIII: "primum non nocere," but what next?重组凝血因子VIII引入引发的主要和次要伦理问题：“首要之务，勿伤患者”，但接下来呢？
Transfus Med Rev. 1992 Oct;6(4):271-6. doi: 10.1016/s0887-7963(92)70181-3.
2
International Symposium on Recombinant Factor VIII: report of the proceedings.重组因子VIII国际研讨会：会议记录报告
Transfus Med Rev. 1992 Apr;6(2):137-45. doi: 10.1016/s0887-7963(92)70163-1.
3
Psychosocial issues surrounding the general or restricted use of recombinant factor VIII: hemophilia clinic perspective.
Transfus Med Rev. 1992 Oct;6(4):277-9. doi: 10.1016/s0887-7963(92)70182-5.
4
Ethical and communal issues in AIDS: an introduction.
Theor Med. 1990 Sep;11(3):173-83. doi: 10.1007/BF00489827.
5
The past and the future: recombinant factor VIII and the consumer.过去与未来：重组凝血因子VIII与消费者
Transfus Med Rev. 1992 Oct;6(4):280-3. doi: 10.1016/s0887-7963(92)70183-7.
6
Recombinant factor VIII in hemophilia.
N Engl J Med. 1991 May 23;324(21):1515-6.
7
The potential impact of recombinant factor VIII on hemophilia care and the demand for blood and blood products.重组凝血因子VIII对血友病治疗以及血液和血液制品需求的潜在影响。
Transfus Med Rev. 1997 Jan;11(1):6-14. doi: 10.1016/s0887-7963(97)80005-3.
8
Inhibitor questions: plasma-derived factor VIII and recombinant factor VIII.
Ann Hematol. 1994;68 Suppl 3:S29-34. doi: 10.1007/BF01774527.
9
Recombinant porcine factor VIII: a new installment of a long story.重组猪源凝血因子VIII：漫长历程中的新篇章。
Haemophilia. 2015 Mar;21(2):149-151. doi: 10.1111/hae.12612. Epub 2015 Feb 6.
10
Health care workers, patients, and HIV: an analysis of the policy and ethical debate.医护人员、患者与艾滋病病毒：政策与伦理辩论分析
Pharos Alpha Omega Alpha Honor Med Soc. 1995 Spring;58(2):7-13.
Zotero 插件